Literature DB >> 7528144

Tachykinins and kinins in antigen-evoked plasma extravasation in guinea-pig nasal mucosa.

F L Ricciardolo1, J A Nadel, C Bertrand, I Yamawaki, B Chan, P Geppetti.   

Abstract

The plasma extravasation evoked by instillation of 5% ovalbumin in the nasal mucosa of sensitized guinea-pigs was potentiated by the neutral endopeptidase inhibitor, phosphoramidon, and was reduced by the tachykinin NK1 receptor antagonist, CP-96,345. The bradykinin B2 receptor antagonist, HOE 140, also reduced the plasma extravasation evoked by the antigen. The combination of HOE 140 and CP-96,345 did not increase further the inhibition caused by HOE 140 alone. Plasma extravasation evoked by instillation of capsaicin was abolished by CP-96,345. HOE 140 blocked and CP-96,345 markedly reduced plasma extravasation caused by instillation of bradykinin. Plasma extravasation evoked by instillation of substance P was not affected by HOE 140. We conclude that antigen challenge causes plasma extravasation in the nasal mucosa of sensitized guinea-pigs, an effect that is due in part to the release of tachykinins from sensory nerve endings. Our evidence suggests that tachykinin release in response to antigen is provoked mainly by the release of kinins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528144     DOI: 10.1016/0014-2999(94)90310-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Inhibition of bradykinin-evoked trigeminal nerve stimulation by the non-peptide bradykinin B2 receptor antagonist WIN 64338 in vivo and in vitro.

Authors:  J M Hall; M Figini; S K Butt; P Geppetti
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

2.  Involvement of tachykinins in plasma extravasation induced by bradykinin and low pH medium in the guinea-pig conjunctiva.

Authors:  M Figini; P Javdan; F Cioncolini; P Geppetti
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.